China’s AI Acceleration Intensifies Competition with US, Sharpens Strategic Choices for South Korea (Reuters-) One year after...
Scaling
Korea Responds to China’s Biopharma Dominance: Looser Listing Rules, Cash R&D Credits, and Venture Ecosystem Overhaul Researchers...